X-linked Charcot-Marie-Tooth disease type 6

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:352675OMIM:300905G60.0
Who is this for?
Show terms as
1Specialists8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

X-linked Charcot-Marie-Tooth disease type 6 (CMTX6) is a very rare inherited nerve disorder that belongs to the broader group of Charcot-Marie-Tooth diseases, which are among the most common inherited conditions affecting the peripheral nerves — the nerves that connect the brain and spinal cord to the rest of the body. CMTX6 is caused by changes (mutations) in the PDK3 gene located on the X chromosome. Because it follows an X-linked inheritance pattern, it primarily affects males more severely, though females who carry the mutation may have milder symptoms or sometimes no symptoms at all. The disease mainly causes progressive damage to the peripheral nerves, leading to muscle weakness and wasting, particularly in the feet, lower legs, hands, and forearms. People with CMTX6 may notice difficulty walking, frequent tripping, foot deformities such as high arches or hammertoes, and reduced sensation in the hands and feet. Some individuals may also experience hearing loss and central nervous system involvement, which can include episodes resembling stroke-like events, particularly during times of physical stress or illness. There is currently no cure for CMTX6. Treatment focuses on managing symptoms and maintaining function. This typically includes physical therapy, occupational therapy, orthopedic devices like braces or special shoes, and sometimes surgery to correct foot deformities. Pain management may also be needed. Research into the underlying mechanisms of this disease is ongoing, and patients are encouraged to work closely with a team of specialists for the best possible care.

Also known as:

Key symptoms:

Muscle weakness in the feet and lower legsMuscle weakness in the hands and forearmsMuscle wasting (loss of muscle bulk) in the limbsHigh arched feet (pes cavus)HammertoesDifficulty walking or frequent trippingFoot drop (difficulty lifting the front of the foot)Numbness or reduced sensation in hands and feetTingling or burning sensations in the extremitiesHearing lossStroke-like episodes during illness or exertionReduced reflexesBalance problemsHand clumsiness or difficulty with fine motor tasks

Clinical phenotype terms (16)— hover any for plain English
EMG: axonal abnormalityHP:0003482Steppage gaitHP:0003376Thenar muscle atrophyHP:0003393
Inheritance

X-linked recessive

Carried on the X chromosome; typically affects males more than females

Age of Onset

Childhood

Begins in childhood, roughly ages 1 to 12

Orphanet ↗OMIM ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for X-linked Charcot-Marie-Tooth disease type 6.

View clinical trials →

No actively recruiting trials found for X-linked Charcot-Marie-Tooth disease type 6 at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the X-linked Charcot-Marie-Tooth disease type 6 community →

Specialists

1 foundView all specialists →
AM
Adeline Vanderver, MD
Los Angeles, California
Specialist

Rare Disease Specialist

PI on 4 active trials1 X-linked Charcot-Marie-Tooth disease type 6 publication

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to X-linked Charcot-Marie-Tooth disease type 6.

Search all travel grants →NORD Financial Assistance ↗

Community

Open X-linked Charcot-Marie-Tooth disease type 6Forum →

No community posts yet. Be the first to share your experience with X-linked Charcot-Marie-Tooth disease type 6.

Start the conversation →

Latest news about X-linked Charcot-Marie-Tooth disease type 6

No recent news articles for X-linked Charcot-Marie-Tooth disease type 6.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Questions for your doctor

Bring these to your next appointment

  • Q1.How severe is the nerve damage right now, and how quickly might it progress?,What physical therapy and rehabilitation programs do you recommend?,Are there any medications or substances I should avoid because they could worsen nerve damage?,What should I do if stroke-like symptoms occur — when should I go to the emergency room?,Should other family members be tested for the PDK3 gene mutation?,Are there any clinical trials or research studies I could participate in?,How often should I have follow-up nerve conduction studies and hearing tests?

Common questions about X-linked Charcot-Marie-Tooth disease type 6

What is X-linked Charcot-Marie-Tooth disease type 6?

X-linked Charcot-Marie-Tooth disease type 6 (CMTX6) is a very rare inherited nerve disorder that belongs to the broader group of Charcot-Marie-Tooth diseases, which are among the most common inherited conditions affecting the peripheral nerves — the nerves that connect the brain and spinal cord to the rest of the body. CMTX6 is caused by changes (mutations) in the PDK3 gene located on the X chromosome. Because it follows an X-linked inheritance pattern, it primarily affects males more severely, though females who carry the mutation may have milder symptoms or sometimes no symptoms at all. The

How is X-linked Charcot-Marie-Tooth disease type 6 inherited?

X-linked Charcot-Marie-Tooth disease type 6 follows a x-linked recessive inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does X-linked Charcot-Marie-Tooth disease type 6 typically begin?

Typical onset of X-linked Charcot-Marie-Tooth disease type 6 is childhood. Age of onset can vary across affected individuals.

Which specialists treat X-linked Charcot-Marie-Tooth disease type 6?

1 specialists and care centers treating X-linked Charcot-Marie-Tooth disease type 6 are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.